Call it T day then. Big investment by SRX in major clinical trials and the results have major implications for future profitability. Head in the sand to pretend otherwise. Baseline business is good, but that won't stop a major sell down if the trials are negative. Hope that the SP drift represents some profit taking/position sizing before the trial results, or a reaction to delayed buyback rather than something more ominous like a leak.
Ann: Update on Proposed $30 million Share Buy-Back, page-33
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $56.24M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $109.3K | 836.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 365703 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 812922 | 5 |
View Market Depth
| Last trade - 15.53pm 28/06/2024 (20 minute delay) ? |
| SRX (ASX) Chart |